These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 5032182

  • 1. [Drug-induced Parkinson's syndrome].
    Degkwitz R.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):882. PubMed ID: 5032182
    [No Abstract] [Full Text] [Related]

  • 2. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J.
    Therapeutique; 1972 Nov 15; 48(9):561-8. PubMed ID: 4650525
    [No Abstract] [Full Text] [Related]

  • 4. [Drug-induced Parkinson's syndrome with cycle-dependent hyperkineses following intake of the contraceptive "Gestakliman"].
    Jörg J.
    Nervenarzt; 1971 Jun 15; 42(6):325-9. PubMed ID: 4397217
    [No Abstract] [Full Text] [Related]

  • 5. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 6. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI, Van Woert MH.
    N Engl J Med; 1971 Feb 25; 284(8):412-5. PubMed ID: 5540479
    [No Abstract] [Full Text] [Related]

  • 7. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD.
    Mod Trends Neurol; 1975 Feb 25; 6():141-66. PubMed ID: 127927
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE, Ferel D, Wurmser P.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):805-13. PubMed ID: 4924276
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of L-DOPA on the akinesis in Parkinson's syndrome].
    Bischoff A.
    Schweiz Med Wochenschr; 1967 Sep 02; 97(35):1158-9. PubMed ID: 5593650
    [No Abstract] [Full Text] [Related]

  • 11. [The drug-induced Parkinson's syndrome].
    Pakesch E.
    Wien Z Nervenheilkd Grenzgeb; 1966 Sep 02; 23(1):140-6. PubMed ID: 4226879
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-induced Parkinson-like syndrome.
    Va Med Mon (1918); 1968 Dec 02; 95(12):746-50 passim. PubMed ID: 5725399
    [No Abstract] [Full Text] [Related]

  • 15. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
    Hornykiewicz OD.
    Neurology; 1970 Dec 02; 20(12):1-5. PubMed ID: 5531292
    [No Abstract] [Full Text] [Related]

  • 16. [Anatomo-clinical aspects of Parkinson's disease and parkinsonian syndromes].
    Gainotti G.
    Riv Neurol; 1978 Dec 02; 48(2):143-92. PubMed ID: 351788
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Logemann G.
    Arzneimittelforschung; 1970 Jul 02; 20(7):894-6. PubMed ID: 5536051
    [No Abstract] [Full Text] [Related]

  • 19. Recent advances in Parkinson's disease.
    Vécsei L.
    Ideggyogy Sz; 2002 Nov 20; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.